Michael Busch
Director, Vitalant Research Institute · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
- Present
Vitalant Research Institute Center · University of California (San Francisco) School of Medicine
Pathology-Anatomic and Clinical
Research
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Nature · 2009 · 1,748 citations
Proceedings of the National Academy of Sciences of the United States of America · 2008 · 1,563 citations
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study
New England Journal of Medicine · 1996 · 1,357 citations
89 papers
43 papers
30 papers
- JZ
29 papers
27 papers
25 papers
- HK
20 papers
- JJ
20 papers
Grants
- 2024–2029
NCIRD · U01
Contact PI · $6M · Vitalant
- 2024–2026
National Heart, Lung, and Blood Institute · R21
Contact PI · $262.5K · Vitalant
- 2019–2021
Biolincc Program: Task Area a - Maintaining and Enhancing the Biolincc Program
National Heart, Lung, and Blood Institute · N02
Contact PI · $8.5M · Information Management Services, Inc.
- 2009–2013
Viral/Immune Parameters of Dengue and WNV in Donors: Blood Safety Implications
National Heart, Lung, and Blood Institute · RC2
Contact PI · $2.1M · Vitalant
Clinical trials
- 2010–2011
- 2008–2011
Principal investigator · Terminated
National Heart, Lung, and Blood Institute (NHLBI)
- 2006–2012
Principal investigator · Completed
Vitalant Research Institute
- 2004–2009
Retrovirus Epidemiology Donor Study-II (REDS-II)
Completed
National Heart, Lung, and Blood Institute (NHLBI)